Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21476640 | 1.00 | ALDH1A1 (0.33) | ALDH1A1MAPK1TDP1HTT | |
| SCHEMBL2911954 | 1.00 | ALDH1A1 (0.33) | ALDH1A1MAPK1TDP1HTT | |
| SCHEMBL2915127 | 0.93 | — | — | |
| SCHEMBL11904134 | 0.93 | — | — | |
| SCHEMBL12806026 | 0.93 | — | — | |
| SCHEMBL14922899 | 0.85 | — | — | |
| SCHEMBL6083462 | 0.85 | — | — | |
| SCHEMBL1300087 | 0.80 | CYP2C9 (0.36) | ALDH1A1MAPK1 | |
| SCHEMBL8488915 | 0.80 | CYP2C9 (0.36) | ALDH1A1MAPK1 | |
| SCHEMBL11434843 | 0.79 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023143777-A1 | PEPTIDE-BASED SYNTHETIC CHLORIDE ION TRANSPORTERS | TAVANTA THERAPEUTICS HUNGARY INCORPORATED (HU) | 2023-08-03 | — | — | WO | disclosed |
| WO-2019200185-A1 | OLIGONUCLEOTIDE COMPOSITIONS AND METHODS OF USE THEREOF | WAVE LIFE SCIENCES LTD. (SG) | 2019-10-17 | — | — | WO | disclosed |
| US-20180104220-A1 | IMIDAZOLE COMPOUND | MEDSHINE DISCOVERY INC. (CN) | 2018-04-19 | — | — | US | disclosed |
| EP-2793928-B1 | PROCESS FOR PURIFYING A SAMPLE OF H38C2 ANTIBODY | PFIZER (US) | 2017-03-15 | — | — | EP | disclosed |
| US-9073864-B2 | Aromatic ring compound | TAKEDA PHARMACEUTICAL COMPANY LIMTED (JP) | 2015-07-07 | — | — | US | disclosed |
| US-20150152052-A1 | AROMATIC RING COMPOUND | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2015-06-04 | — | — | US | disclosed |
| CN-103254902-B | Fluorine-containing liquid crystal compound containing ethane bridged bond and -CF2O- bridged bond | XIAN MODERN CHEMISTRY RES INST | 2015-02-11 | — | — | CN | disclosed |
| CN-103145525-B | Synthesis method of 1 - fluoro - 3 - [2 - (trans- 4 - alkyl cyclohexyl) ethyl] benzene | XIAN MODERN CHEMISTRY RES INST | 2015-02-11 | — | — | CN | disclosed |
| CN-103242133-B | Synthesis method of 4-[2-(trans-4-alkylcyclohexyl)ethyl] bromobenzene | XIAN MODERN CHEMISTRY RES INST | 2015-02-11 | — | — | CN | disclosed |
| CN-103242854-B | Fluorine-containing liquid crystal compound | XI'AN INST. OF MODERN CHEMISTRY (CN) | 2014-10-15 | — | — | CN | disclosed |
| EP-2382995-A2 | Ligand conjugates of Vinca alkaloids, analogs and derivatives | Endocyte, Inc. (US) | 2011-11-02 | — | — | EP | disclosed |
| EP-2339014-A1 | Methods and compositions comprising non-natural amino acids | AMBRX, INC. (US) | 2011-06-29 | — | — | EP | disclosed |
| EP-1640433-B1 | CHROMAN DERIVATIVE AND LIQUID-CRYSTAL COMPOSITION CONTAINING THE COMPOUND | DAINIPPON INK & CHEMICALS (JP) | 2010-08-25 | — | — | EP | disclosed |
| US-7226644-B2 | Chroman derivative and liquid-crystal composition containing the compound | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2007-06-05 | — | — | US | disclosed |
| US-7226644-B2 | Chroman derivative and liquid-crystal composition containing the compound | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2007-06-05 | — | — | US | disclosed |
| CN-1088453-C | Fluorine-substituted liquid-crystal compound, liquid-crystal composition and liquid-crystal display device | CHISSO CORP (JP) | 2002-07-31 | — | — | CN | disclosed |
| US-4264495-A | EXHIBITING GOOD COLOFASTNESS AND DYEABILITY ON POLYAMIDES AND OTHER FIBERS | EASTMAN KODAK COMPANY (US) | 1981-04-28 | — | — | US | disclosed |
| US-4247458-A | COUPLING DIAZONIUM SALT WITH DISPERSE DYE COUPLER WITH DISPLACEABLE GROUP OTHER THAN HYDROGEN | EASTMAN KODAK COMPANY (US) | 1981-01-27 | — | — | US | disclosed |
| US-4070352-A | COLORFAST, SUBLIMATION AND OZONE RESISTANT BLUE AZO DYES FOR POLYAMIDES | EASTMAN KODAK COMPANY (US) | 1978-01-24 | — | — | US | disclosed |
| US-4053526-A | PROCESS FOR ISOLATING DINITRONAPHTHALENES | BAYER AKTIENGESELLSCHAFT (DT) | 1977-10-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150152052-A1 | AROMATIC RING COMPOUND | GLP1R, GCGR, IAPP | ALDH1A1 3434/4885MAPK1 148/4885TDP1 4368/4885 |
| US-20180104220-A1 | IMIDAZOLE COMPOUND | MAPT, SLC10A2, SLC5A11 | ALDH1A1 1316/4885MAPK1 2826/4885TDP1 1221/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.